KB Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$118K Buy
219
+42
+24% +$21.6K 0.03% 183
2023
Q2
$83K Buy
177
+121
+216% +$50.7K 0.02% 219
2023
Q1
$19K Hold
56
0.01% 351
2022
Q4
$20K Hold
56
0.01% 347
2022
Q3
$18K Hold
56
0.01% 342
2022
Q2
$18K Hold
56
0.01% 339
2022
Q1
$16K Sell
56
-9
-14% -$2.32K ﹤0.01% 375
2021
Q4
$18K Buy
+65
New +$16.5K 0.01% 378
2021
Q3
Sell
-56
Closed -$13K 390
2021
Q2
$13K Hold
56
﹤0.01% 385
2021
Q1
$10K Buy
+56
New +$11K ﹤0.01% 445

Other funds holding LLY

KB Financial Partners's LLY Position: Q3 2023 in Review

KB Financial Partners increased its Eli Lilly (LLY) stake by 24% in Q3 2023, buying an estimated $21.6K and bringing the position to 219 shares worth $118K. The position accounts for 0.03% of the portfolio, ranked #183.

KB Financial Partners first reported a position in LLY in Q1 2021 and has held it in 10 quarters since. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • KB Financial Partners held 219 shares of Eli Lilly worth $118K as of Q3 2023.
  • KB Financial Partners bought 42 Eli Lilly shares in Q3 2023, an estimated $21.6K.
  • Eli Lilly made up 0.03% of KB Financial Partners's portfolio in Q3 2023, its #183 holding.
  • KB Financial Partners first reported a position in Eli Lilly in Q1 2021 and has held it in 10 quarters since.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.